Avandia Linked to Heart Failure

The diabetes drug Avandia has recently been linked to episodes of heart attacks and heart failure in its users.  The New York Times received reports suggesting that Avandia, known as rosiglitazone, was linked to at least 304 deaths during the third quarter of 2009.  "Rosiglitazone should be removed from the market," stated Dr. David Graham of the Food and Drug Administration in the article.  A recent investigation by the U.S. Senate found that GlaxoSmithKline, the manufacturer of Avandia, should have warned patients of the drug's potential risks.  Instead, Senators Max Baucus and Charles Grassley contend that GlaxoSmithKline executives attempted to intimidate physicians and minimize reports that Avandia increased cardiovascular risks. GlaxoSmithKline, however, insists it condones scientific debate, but concedes the situation "could have been handled differently."   Those taking the drug should consult their personal physician if they have concerns.  If you or a loved one has suffered a serious cardiovascular event as a result of taking Avandia, you should consider consulting an attorney to discuss your legal rights.  Our staff is available 24 hours a day at 888-973-2540 (888-WRECK-404) for a free consultation.